These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34934932)

  • 1. GFAT2 mediates cardiac hypertrophy through HBP-O-GlcNAcylation-Akt pathway.
    Ishikita A; Matsushima S; Ikeda S; Okabe K; Nishimura R; Tadokoro T; Enzan N; Yamamoto T; Sada M; Tsutsui Y; Miyake R; Ikeda M; Ide T; Kinugawa S; Tsutsui H
    iScience; 2021 Dec; 24(12):103517. PubMed ID: 34934932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2.
    Nabeebaccus AA; Verma S; Zoccarato A; Emanuelli G; Santos CX; Streckfuss-Bömeke K; Shah AM
    Biochem Biophys Res Commun; 2021 Dec; 583():121-127. PubMed ID: 34735873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide Induces GFAT2 Expression to Promote
    Al-Mukh H; Baudoin L; Bouaboud A; Sanchez-Salgado JL; Maraqa N; Khair M; Pagesy P; Bismuth G; Niedergang F; Issad T
    J Immunol; 2020 Nov; 205(9):2499-2510. PubMed ID: 32978282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression.
    Dai W; Dierschke SK; Toro AL; Dennis MD
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3568-3576. PubMed ID: 30254013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hexosamine Biosynthesis Pathway: Regulation and Function.
    Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.
    Gélinas R; Mailleux F; Dontaine J; Bultot L; Demeulder B; Ginion A; Daskalopoulos EP; Esfahani H; Dubois-Deruy E; Lauzier B; Gauthier C; Olson AK; Bouchard B; Des Rosiers C; Viollet B; Sakamoto K; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S; Bertrand L
    Nat Commun; 2018 Jan; 9(1):374. PubMed ID: 29371602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
    Prisco SZ; Rose L; Potus F; Tian L; Wu D; Hartweck L; Al-Qazazi R; Neuber-Hess M; Eklund M; Hsu S; Thenappan T; Archer SL; Prins KW
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.
    Marsh SA; Dell'Italia LJ; Chatham JC
    Amino Acids; 2011 Mar; 40(3):819-28. PubMed ID: 20676904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal regulation of protein O-GlcNAc levels during pressure-overload cardiac hypertrophy.
    Zhu WZ; Ledee D; Olson AK
    Physiol Rep; 2021 Aug; 9(15):e14965. PubMed ID: 34337900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFAT1/HBP/O-GlcNAcylation Axis Regulates
    Jia C; Li H; Fu D; Lan Y
    Biomed Res Int; 2020; 2020():1921609. PubMed ID: 32149084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexosamines, insulin resistance, and the complications of diabetes: current status.
    Buse MG
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
    Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
    J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
    Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
    J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of mouse glutamine-fructose-6-phosphate amidotransferase 2 (GFAT2) by cAMP-dependent protein kinase increases the enzyme activity.
    Hu Y; Riesland L; Paterson AJ; Kudlow JE
    J Biol Chem; 2004 Jul; 279(29):29988-93. PubMed ID: 15133036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose.
    Ducheix S; Magré J; Cariou B; Prieur X
    Front Endocrinol (Lausanne); 2018; 9():642. PubMed ID: 30420836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress.
    Walter LA; Lin YH; Halbrook CJ; Chuh KN; He L; Pedowitz NJ; Batt AR; Brennan CK; Stiles BL; Lyssiotis CA; Pratt MR
    Biochemistry; 2020 Sep; 59(34):3169-3179. PubMed ID: 31625393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 19. Excessive O-GlcNAcylation of proteins suppresses spontaneous cardiogenesis in ES cells.
    Kim HS; Park SY; Choi YR; Kang JG; Joo HJ; Moon WK; Cho JW
    FEBS Lett; 2009 Aug; 583(15):2474-8. PubMed ID: 19591829
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang H; Qi J; Pei J; Zhang M; Shang Y; Li Z; Wang Y; Guo J; Sun K; Fan J; Sui L; Xu Y; Kong L; Kong Y
    J Adv Res; 2022 Mar; 37():119-131. PubMed ID: 35499042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.